Editorial
Published on 05 May 2023
Editorial: Non-reactogenic vaccines against Q-fever
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1196522
- 2,168 views
Type at least 3 characters
2,253 articles
Original Research
Published on 05 May 2023
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1166589
- 3,677 views
- 10 citations
Original Research
Published on 05 May 2023
A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1192395
- 3,087 views
- 2 citations
Original Research
Published on 03 May 2023
Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1154818
- 3,266 views
- 9 citations
Original Research
Published on 02 May 2023
A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1085911
- 3,743 views
- 1 citation
Original Research
Published on 01 May 2023
Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1163858
- 7,659 views
- 5 citations
Brief Research Report
Published on 28 Apr 2023
Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1161571
- 2,475 views
Original Research
Published on 27 Apr 2023
Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1146841
- 3,982 views
- 13 citations
Original Research
Published on 27 Apr 2023
Parents‘ and healthcare professionals’ perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1052450
- 2,839 views
Original Research
Published on 27 Apr 2023
A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1124695
- 3,457 views
- 6 citations
Hypothesis and Theory
Published on 26 Apr 2023
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1183258
- 4,747 views
- 12 citations
Original Research
Published on 26 Apr 2023
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1156714
- 3,737 views
- 6 citations
Study Protocol
Published on 26 Apr 2023
Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1140677
- 1,489 views
Review
Published on 24 Apr 2023
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1172691
- 16,353 views
- 42 citations
Review
Published on 21 Apr 2023
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1064459
- 5,317 views
- 6 citations
Original Research
Published on 21 Apr 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1182963
- 4,598 views
- 9 citations